Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-114022
Filing Date
2024-10-10
Accepted
2024-10-10 14:14:11
Documents
59
Period of Report
2024-08-31

Document Format Files

Seq Description Document Type Size
1 10-Q neog-20240831.htm   iXBRL 10-Q 1294768
2 EX-31.1 neog-ex31_1.htm EX-31.1 14494
3 EX-31.2 neog-ex31_2.htm EX-31.2 14294
4 EX-32 neog-ex32.htm EX-32 11337
5 GRAPHIC img193737124_0.jpg GRAPHIC 646845
  Complete submission text file 0000950170-24-114022.txt   7937195

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT neog-20240831.xsd EX-101.SCH 1354458
61 EXTRACTED XBRL INSTANCE DOCUMENT neog-20240831_htm.xml XML 891018
Mailing Address 620 LESHER PLACE LANSING MI 48912
Business Address 620 LESHER PLACE LANSING MI 48912 5173729200
NEOGEN CORP (Filer) CIK: 0000711377 (see all company filings)

EIN.: 382367843 | State of Incorp.: MI | Fiscal Year End: 0531
Type: 10-Q | Act: 34 | File No.: 000-17988 | Film No.: 241364791
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)